Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Becton, Dickinson and Co. — Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

27 daysmedian FDA review time
101 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K152870BD Veritor System for the Rapid Detection of Flu A + B CLIA Becton, Dickinson and Co.2015-10-27270
K152874BD Veritor System for the Rapid Detection of Flu A + B LaborBecton, Dickinson and Co.2015-10-27270
K100005BD PEN NEEDLEBecton, Dickinson and Co.2010-04-151010
K041572BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERCILLIN (GN) 0.Becton, Dickinson and Co.2004-08-12590
K010890BD ULTRA-FINE II INSULIN SYRINGE-MINI NEEDLE, MODEL 30G * 3/Becton, Dickinson and Co.2001-04-19240
K010572BD VISIDRAPE OPHTHALMIC DRAPES; BD VISIFLEX INCISE DRAPEBecton, Dickinson and Co.2001-03-12140

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda